Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction
As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....
407 Views
Samsung's Top & Backup Options for Restructuring - Prediction on Its Response to Elliott
Korea's Fair Trade Commission official (Kim Jung-ki) has officially said last week (Nov 1) that FTC would submit an amendment to the current fair...
335 Views
What to Expect from Samsung's Board Meeting Today on Shareholder Policy for Elliott
It looks like Elliott, once Samsung's most hated foe, has become Samsung's new best friend. Elliott seems to be loving every action and decision...
320 Views
Korea National Pension Fund - Commitment to Buy 1 Trillion Won Worth of Small Cap Stocks in Korea
On October 26th, The Korea National Pension Fund (KNPF) announced that it will purchase 1 trillion won worth of small-mid cap stocks on the Korean...
240 Views
Samsung BioLogics IPO - Why Investors Are Excited & Concerned
Samsung BioLogics will have a big day tomorrow. Nov 2-3 will be the subscription day. The company has already had a huge success with the...
436 Views